Report cover image

Global Prothrombin Complex Concentrate(PCC) Industry Growth and Trends Forecast to 2031

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 106 Pages
SKU # APRC20354076

Description

Summary

According to APO Research, The global Prothrombin Complex Concentrate(PCC) market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Prothrombin Complex Concentrate(PCC) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Prothrombin Complex Concentrate(PCC) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Prothrombin Complex Concentrate(PCC) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of Prothrombin Complex Concentrate(PCC) include CSL, WEIGUANG BIOLOGICAL, Taibang Biologic Group, SHANGHAI RAAS, Green Cross, Jiangxi Boya Bio-Pharmaceutical, HUALAN BIOLOGICAL ENGINEERING, Guangdong Shuanglin Biopharmaceutical and Beijing Tiantan Biological Products, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Prothrombin Complex Concentrate(PCC), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prothrombin Complex Concentrate(PCC).

The Prothrombin Complex Concentrate(PCC) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Prothrombin Complex Concentrate(PCC) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Prothrombin Complex Concentrate(PCC) Segment by Company

CSL
WEIGUANG BIOLOGICAL
Taibang Biologic Group
SHANGHAI RAAS
Green Cross
Jiangxi Boya Bio-Pharmaceutical
HUALAN BIOLOGICAL ENGINEERING
Guangdong Shuanglin Biopharmaceutical
Beijing Tiantan Biological Products
BOHUI
Biotest

Prothrombin Complex Concentrate(PCC) Segment by Type

1000IU
100IU
200IU
300IU
400IU

Prothrombin Complex Concentrate(PCC) Segment by Application

Hopistial
Clinic
Others

Prothrombin Complex Concentrate(PCC) Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prothrombin Complex Concentrate(PCC) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Prothrombin Complex Concentrate(PCC) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prothrombin Complex Concentrate(PCC).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prothrombin Complex Concentrate(PCC) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Prothrombin Complex Concentrate(PCC) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Table of Contents

106 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Prothrombin Complex Concentrate(PCC) Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Prothrombin Complex Concentrate(PCC) Sales Estimates and Forecasts (2020-2031)
1.3 Prothrombin Complex Concentrate(PCC) Market by Type
1.3.1 1000IU
1.3.2 100IU
1.3.3 200IU
1.3.4 300IU
1.3.5 400IU
1.4 Global Prothrombin Complex Concentrate(PCC) Market Size by Type
1.4.1 Global Prothrombin Complex Concentrate(PCC) Market Size Overview by Type (2020-2031)
1.4.2 Global Prothrombin Complex Concentrate(PCC) Historic Market Size Review by Type (2020-2025)
1.4.3 Global Prothrombin Complex Concentrate(PCC) Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Prothrombin Complex Concentrate(PCC) Sales Breakdown by Type (2020-2025)
1.5.2 Europe Prothrombin Complex Concentrate(PCC) Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Prothrombin Complex Concentrate(PCC) Sales Breakdown by Type (2020-2025)
1.5.4 South America Prothrombin Complex Concentrate(PCC) Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Prothrombin Complex Concentrate(PCC) Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics
2.1 Prothrombin Complex Concentrate(PCC) Industry Trends
2.2 Prothrombin Complex Concentrate(PCC) Industry Drivers
2.3 Prothrombin Complex Concentrate(PCC) Industry Opportunities and Challenges
2.4 Prothrombin Complex Concentrate(PCC) Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Prothrombin Complex Concentrate(PCC) Revenue (2020-2025)
3.2 Global Top Players by Prothrombin Complex Concentrate(PCC) Sales (2020-2025)
3.3 Global Top Players by Prothrombin Complex Concentrate(PCC) Price (2020-2025)
3.4 Global Prothrombin Complex Concentrate(PCC) Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Prothrombin Complex Concentrate(PCC) Major Company Production Sites & Headquarters
3.6 Global Prothrombin Complex Concentrate(PCC) Company, Product Type & Application
3.7 Global Prothrombin Complex Concentrate(PCC) Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Prothrombin Complex Concentrate(PCC) Market CR5 and HHI
3.8.2 Global Top 5 and 10 Prothrombin Complex Concentrate(PCC) Players Market Share by Revenue in 2024
3.8.3 2023 Prothrombin Complex Concentrate(PCC) Tier 1, Tier 2, and Tier 3
4 Prothrombin Complex Concentrate(PCC) Regional Status and Outlook
4.1 Global Prothrombin Complex Concentrate(PCC) Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Prothrombin Complex Concentrate(PCC) Historic Market Size by Region
4.2.1 Global Prothrombin Complex Concentrate(PCC) Sales in Volume by Region (2020-2025)
4.2.2 Global Prothrombin Complex Concentrate(PCC) Sales in Value by Region (2020-2025)
4.2.3 Global Prothrombin Complex Concentrate(PCC) Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Prothrombin Complex Concentrate(PCC) Forecasted Market Size by Region
4.3.1 Global Prothrombin Complex Concentrate(PCC) Sales in Volume by Region (2026-2031)
4.3.2 Global Prothrombin Complex Concentrate(PCC) Sales in Value by Region (2026-2031)
4.3.3 Global Prothrombin Complex Concentrate(PCC) Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 Prothrombin Complex Concentrate(PCC) by Application
5.1 Prothrombin Complex Concentrate(PCC) Market by Application
5.1.1 Hopistial
5.1.2 Clinic
5.1.3 Others
5.2 Global Prothrombin Complex Concentrate(PCC) Market Size by Application
5.2.1 Global Prothrombin Complex Concentrate(PCC) Market Size Overview by Application (2020-2031)
5.2.2 Global Prothrombin Complex Concentrate(PCC) Historic Market Size Review by Application (2020-2025)
5.2.3 Global Prothrombin Complex Concentrate(PCC) Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Prothrombin Complex Concentrate(PCC) Sales Breakdown by Application (2020-2025)
5.3.2 Europe Prothrombin Complex Concentrate(PCC) Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Prothrombin Complex Concentrate(PCC) Sales Breakdown by Application (2020-2025)
5.3.4 South America Prothrombin Complex Concentrate(PCC) Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Prothrombin Complex Concentrate(PCC) Sales Breakdown by Application (2020-2025)
6 Company Profiles
6.1 CSL
6.1.1 CSL Comapny Information
6.1.2 CSL Business Overview
6.1.3 CSL Prothrombin Complex Concentrate(PCC) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 CSL Prothrombin Complex Concentrate(PCC) Product Portfolio
6.1.5 CSL Recent Developments
6.2 WEIGUANG BIOLOGICAL
6.2.1 WEIGUANG BIOLOGICAL Comapny Information
6.2.2 WEIGUANG BIOLOGICAL Business Overview
6.2.3 WEIGUANG BIOLOGICAL Prothrombin Complex Concentrate(PCC) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 WEIGUANG BIOLOGICAL Prothrombin Complex Concentrate(PCC) Product Portfolio
6.2.5 WEIGUANG BIOLOGICAL Recent Developments
6.3 Taibang Biologic Group
6.3.1 Taibang Biologic Group Comapny Information
6.3.2 Taibang Biologic Group Business Overview
6.3.3 Taibang Biologic Group Prothrombin Complex Concentrate(PCC) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Taibang Biologic Group Prothrombin Complex Concentrate(PCC) Product Portfolio
6.3.5 Taibang Biologic Group Recent Developments
6.4 SHANGHAI RAAS
6.4.1 SHANGHAI RAAS Comapny Information
6.4.2 SHANGHAI RAAS Business Overview
6.4.3 SHANGHAI RAAS Prothrombin Complex Concentrate(PCC) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 SHANGHAI RAAS Prothrombin Complex Concentrate(PCC) Product Portfolio
6.4.5 SHANGHAI RAAS Recent Developments
6.5 Green Cross
6.5.1 Green Cross Comapny Information
6.5.2 Green Cross Business Overview
6.5.3 Green Cross Prothrombin Complex Concentrate(PCC) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Green Cross Prothrombin Complex Concentrate(PCC) Product Portfolio
6.5.5 Green Cross Recent Developments
6.6 Jiangxi Boya Bio-Pharmaceutical
6.6.1 Jiangxi Boya Bio-Pharmaceutical Comapny Information
6.6.2 Jiangxi Boya Bio-Pharmaceutical Business Overview
6.6.3 Jiangxi Boya Bio-Pharmaceutical Prothrombin Complex Concentrate(PCC) Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Jiangxi Boya Bio-Pharmaceutical Prothrombin Complex Concentrate(PCC) Product Portfolio
6.6.5 Jiangxi Boya Bio-Pharmaceutical Recent Developments
6.7 HUALAN BIOLOGICAL ENGINEERING
6.7.1 HUALAN BIOLOGICAL ENGINEERING Comapny Information
6.7.2 HUALAN BIOLOGICAL ENGINEERING Business Overview
6.7.3 HUALAN BIOLOGICAL ENGINEERING Prothrombin Complex Concentrate(PCC) Sales, Revenue and Gross Margin (2020-2025)
6.7.4 HUALAN BIOLOGICAL ENGINEERING Prothrombin Complex Concentrate(PCC) Product Portfolio
6.7.5 HUALAN BIOLOGICAL ENGINEERING Recent Developments
6.8 Guangdong Shuanglin Biopharmaceutical
6.8.1 Guangdong Shuanglin Biopharmaceutical Comapny Information
6.8.2 Guangdong Shuanglin Biopharmaceutical Business Overview
6.8.3 Guangdong Shuanglin Biopharmaceutical Prothrombin Complex Concentrate(PCC) Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Guangdong Shuanglin Biopharmaceutical Prothrombin Complex Concentrate(PCC) Product Portfolio
6.8.5 Guangdong Shuanglin Biopharmaceutical Recent Developments
6.9 Beijing Tiantan Biological Products
6.9.1 Beijing Tiantan Biological Products Comapny Information
6.9.2 Beijing Tiantan Biological Products Business Overview
6.9.3 Beijing Tiantan Biological Products Prothrombin Complex Concentrate(PCC) Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Beijing Tiantan Biological Products Prothrombin Complex Concentrate(PCC) Product Portfolio
6.9.5 Beijing Tiantan Biological Products Recent Developments
6.10 BOHUI
6.10.1 BOHUI Comapny Information
6.10.2 BOHUI Business Overview
6.10.3 BOHUI Prothrombin Complex Concentrate(PCC) Sales, Revenue and Gross Margin (2020-2025)
6.10.4 BOHUI Prothrombin Complex Concentrate(PCC) Product Portfolio
6.10.5 BOHUI Recent Developments
6.11 Biotest
6.11.1 Biotest Comapny Information
6.11.2 Biotest Business Overview
6.11.3 Biotest Prothrombin Complex Concentrate(PCC) Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Biotest Prothrombin Complex Concentrate(PCC) Product Portfolio
6.11.5 Biotest Recent Developments
7 North America by Country
7.1 North America Prothrombin Complex Concentrate(PCC) Sales by Country
7.1.1 North America Prothrombin Complex Concentrate(PCC) Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Prothrombin Complex Concentrate(PCC) Sales by Country (2020-2025)
7.1.3 North America Prothrombin Complex Concentrate(PCC) Sales Forecast by Country (2026-2031)
7.2 North America Prothrombin Complex Concentrate(PCC) Market Size by Country
7.2.1 North America Prothrombin Complex Concentrate(PCC) Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Prothrombin Complex Concentrate(PCC) Market Size by Country (2020-2025)
7.2.3 North America Prothrombin Complex Concentrate(PCC) Market Size Forecast by Country (2026-2031)
8 Europe by Country
8.1 Europe Prothrombin Complex Concentrate(PCC) Sales by Country
8.1.1 Europe Prothrombin Complex Concentrate(PCC) Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Prothrombin Complex Concentrate(PCC) Sales by Country (2020-2025)
8.1.3 Europe Prothrombin Complex Concentrate(PCC) Sales Forecast by Country (2026-2031)
8.2 Europe Prothrombin Complex Concentrate(PCC) Market Size by Country
8.2.1 Europe Prothrombin Complex Concentrate(PCC) Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Prothrombin Complex Concentrate(PCC) Market Size by Country (2020-2025)
8.2.3 Europe Prothrombin Complex Concentrate(PCC) Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country
9.1 Asia-Pacific Prothrombin Complex Concentrate(PCC) Sales by Country
9.1.1 Asia-Pacific Prothrombin Complex Concentrate(PCC) Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Prothrombin Complex Concentrate(PCC) Sales by Country (2020-2025)
9.1.3 Asia-Pacific Prothrombin Complex Concentrate(PCC) Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Prothrombin Complex Concentrate(PCC) Market Size by Country
9.2.1 Asia-Pacific Prothrombin Complex Concentrate(PCC) Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Prothrombin Complex Concentrate(PCC) Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Prothrombin Complex Concentrate(PCC) Market Size Forecast by Country (2026-2031)
10 South America by Country
10.1 South America Prothrombin Complex Concentrate(PCC) Sales by Country
10.1.1 South America Prothrombin Complex Concentrate(PCC) Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Prothrombin Complex Concentrate(PCC) Sales by Country (2020-2025)
10.1.3 South America Prothrombin Complex Concentrate(PCC) Sales Forecast by Country (2026-2031)
10.2 South America Prothrombin Complex Concentrate(PCC) Market Size by Country
10.2.1 South America Prothrombin Complex Concentrate(PCC) Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Prothrombin Complex Concentrate(PCC) Market Size by Country (2020-2025)
10.2.3 South America Prothrombin Complex Concentrate(PCC) Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country
11.1 Middle East and Africa Prothrombin Complex Concentrate(PCC) Sales by Country
11.1.1 Middle East and Africa Prothrombin Complex Concentrate(PCC) Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Prothrombin Complex Concentrate(PCC) Sales by Country (2020-2025)
11.1.3 Middle East and Africa Prothrombin Complex Concentrate(PCC) Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Prothrombin Complex Concentrate(PCC) Market Size by Country
11.2.1 Middle East and Africa Prothrombin Complex Concentrate(PCC) Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Prothrombin Complex Concentrate(PCC) Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Prothrombin Complex Concentrate(PCC) Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis
12.1 Prothrombin Complex Concentrate(PCC) Value Chain Analysis
12.1.1 Prothrombin Complex Concentrate(PCC) Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Prothrombin Complex Concentrate(PCC) Production Mode & Process
12.2 Prothrombin Complex Concentrate(PCC) Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Prothrombin Complex Concentrate(PCC) Distributors
12.2.3 Prothrombin Complex Concentrate(PCC) Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.